The Cost of Institutional Review Board Procedures in Multicenter Observational Research [3]

Annals of Internal Medicine

Volumn 139, Issue 1, 2003, Pages 77-

  Humphreys, Keith ^a   Trafton, Jodie ^a   Wagner, Todd H ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMIC EVALUATION; FINANCIAL MANAGEMENT; HOSPITAL; HUMAN; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; BIOMEDICAL AND BEHAVIORAL RESEARCH; COST; ECONOMICS; MULTICENTER STUDY; PROFESSIONAL STANDARD; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

COSTS AND COST ANALYSIS; ETHICS COMMITTEES, RESEARCH; HUMANS; MULTICENTER STUDIES; UNITED STATES;

EID: 1642453693     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-1-200307010-00021     Document Type: Letter

References (5)

1. Burman WJ, Reves RR, Cohn DL, Schooley RT. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med. 2001;134:152-7. [PMID: 11177319]
2. Wagner TH, Bhandari A, Chadwick GL, Nelson DK. The cost of operating institutional review boards (IRBs). Acad Med 2003;178: [In press].
3. Christian MC, Goldberg JL, Killen J, Abrams JS, McCabe MS, Mauer JK, et al. A central institutional review board for multi-institutional trials. N Engl J Med. 2002;346:1405-8. [PMID: 11986418]
4. New beryllium IRB. Department of Energy. Protecting Human Subjects. 2001-02; Winter:1, 6-7. Accessed at www.science.doe.gov/ober/humsubj/winter01.pdf on 13 June 2002.
5. Middle C, Johnson A, Petty T, Sims L, Macfarlane A. Ethics approval for a national postal survey: recent experience. BMJ. 1995;311:659-60. [PMID: 7549633]